Impacts of the COVID-19 Pandemic on Organ Donation and Transplantation Activities: Global Scenario

Josélio Emar de Araújo Queiroz; Francisco Álisson Paula de França; Rodrigo Fonseca Lima; Rafael Santos Santana; Elivan Silva Souza; Fernando Antibas Atik; José Osmar Medina de Abreu Pestana; Lídia Einsfeld

Autores

Josélio Emar de Araújo Queiroz Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil. https://orcid.org/0000-0002-1549-4045
Francisco Álisson Paula de França Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil. https://orcid.org/0000-0002-5579-6785
Rodrigo Fonseca Lima Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil. https://orcid.org/0000-0001-8173-4425
Rafael Santos Santana Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil. https://orcid.org/0000-0003-4481-210X
Elivan Silva Souza Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil. https://orcid.org/0000-0001-5143-2362
Fernando Antibas Atik Instituto de Cardiologia do Distrito Federal – Brasília (DF), Brasil. https://orcid.org/0000-0003-3394-9493
José Osmar Medina de Abreu Pestana Universidade Federal de São Paulo – Faculdade de Medicina – São Paulo (SP), Brasil. https://orcid.org/0000-0002-0750-7360
Lídia Einsfeld Universidade de Brasília – Faculdade de Ciências da Saúde – Laboratório de Evidências e Estudos Farmacêuticos – Departamento de Farmácia – Brasília (DF), Brasil|Universidade Federal do Rio Grande do Sul – Hospital de Clínicas de Porto Alegre – Porto Alegre (RS), Brasil. https://orcid.org/0000-0002-5222-233X

Palavras-chave:

Atenção à Saúde, COVID-19, Indicadores e Reagentes, Transplante de Órgãos

Resumo

O objetivo deste estudo foi avaliar o impacto da pandemia de COVID-19 no processo de doação e transplante no contexto global. Métodos: Foi realizado um estudo ecológico de 2017 a 2021, examinando o número de doadores e transplantes, bem como os casos e óbitos relacionados à COVID-19. A análise de regressão linear simples foi utilizada em dois blocos: entre 2017 e 2020 e entre 2017 e 2021. Foram consideradas taxas por milhão de habitantes para avaliar os impactos. Resultados: O estudo incluiu 10 países, e Portugal apresentou o impacto mais significativo na taxa de doadores efetivos, com redução de 4.463,8 (intervalo de confiança de 95% [95%CI] -5.103,2–-3.824,4), seguido por Espanha (-3.964,4; 95%CI: -5.850,2–-2.078,6), México (-3.879,3; 95%CI -4.688,6–-3.069,9) e Austrália (-309; 95%CI -565,3–-52,7), ao contrário dos Estados Unidos, que apresentaram aumento. Em termos de taxas de transplante, destacam-se Brasil, Portugal, Espanha, França, Irã e México, que apresentaram redução. Conclusão: A pandemia de COVID-19 causou impactos significativos no processo de doação e transplante em diversos países, e a caracterização desses efeitos é fundamental para a retomada das atividades.

Downloads

Não há dados estatísticos.

Referências

1 Medina-Pestana JO, Galante NZ, Tedesco-Silva H Jr, Harada KM, Garcia VD, Abbud-Filho M, Campos HH, Sabbaga E. O contexto do transplante renal no Brasil e sua disparidade geográfica. J Bras Nefrol. 2011; 33 (4): 472-84. https://doi.org/10.1590/S0101-28002011000400014

2 Westphal GA, Garcia VD, Souza RL, Franke CA, Vieira KD, Birckholz VRZ, Machado MC, Almeida ERB, Machado FO, Sardinha LAC, Wanzuita R, Silvado CES, Costa G, Braatz V, Caldeira Filho M, Furtado R, Tannous LA, Albuquerque AGN, Abdala E, Gonçalves ARR, Pacheco-Moreira LF, Dias FS, Fernandes R, Di Giovanni F, Carvalho FB, Fiorelli A, Teixeira C, Feijó C, Camargo SM, Oliveira NE, David AI, Prinz RAD, Herranz LB, Andrade J. Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva. 2016; 28 (3): 220-55. https://doi.org/10.5935/0103-507X.20160049

3 Gois RSS, Galdino MJQ, Pissinati PSC, Pimentel RRS, Carvalho MDB, Haddad MCFL. Efetividade do processo de doação de órgãos para transplantes. Acta Paul Enferm. 2017; 30 (6): 621-7. https://doi.org/10.1590/1982-0194201700089

4 Garcia CD, Pereira JD, Garcia VD, editors. Doação e transplante de órgãos e tecidos. São Paulo: Segmento Farma; 2015.

5 Soares LS, Brito ES, Magedanz L, França FA, Araújo WN, Galato D. Solid organ transplantation in Brazil: a descriptive study of distribution and access inequalities, 2001–2017. Epidemiol Serv Saúde. 2020; 29 (1): e2018512. https://doi.org/10.5123/S1679-49742020000100014

6 Weiss MJ, Lalani J, Patriquin-Stoner C, Dieudé M, Hartell D, Hornby L, Shemie SD, Wilson L, Mah A. Summary of international recommendations for donation and transplantation programs during the COVID-19 pandemic. Transplantation. 2021;105 (1): 14-7. https://doi.org/10.1097/TP.0000000000003520

7 Aubert O, Yoo D, Zielinski D, Cozzi E, Cardillo M, Dürr M, Domínguez-Gil B, Coll E, Silva MID, Sallinen V, Lemström K, Midtvedt K, Ulloa C, Immer F, Weissenbacher A, Vallant N, Basic-Jukic N, Tanabe K, Papatheodoridis G, Menoudakou G, Torres M, Soratti C, Krogh DH, Lefaucheur C, Ferreira G, Silva HT Jr, Hartell D, Forsythe J, Mumford L, Reese PP, Kerbaul F, Jacquelinet C, Vogelaar S, Papalois V, Loupy A. COVID-19 pandemic and worldwide organ transplantation: a population-based study. Lancet Public Health. 2021; 6 (10): e709-19. https://doi.org/10.1016/S2468-2667(21)00200-0

8 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

9 Gaussen A, Hornby L, Rockl G, O'Brien S, Delage G, Sapir-Pichhadze R, Drews SJ, Weiss MJ, Lewin A. Evidence of SARS-CoV-2 infection in cells, tissues, and organs and the risk of transmission through transplantation. Transplantation. 2021; 105 (7): 1405-22. https://doi.org/10.1097/TP.0000000000003744

10 Turco C, Lim C, Soubrane O, Malaquin G, Kerbaul F, Bastien O, Conti F, Scatton O. Impact of the first COVID-19 outbreak on liver transplantation activity in France: A snapshot. Clin Res Hepatol Gastroenterol. 2021; 45 (4): 101560. https://doi.org/10.1016/j.clinre.2020.10.005

11 Ahmadi ZH, Mousavizadeh M, Nikpajouh A, Bahsir M, Hosseini S. COVID‐19: A perspective from Iran. J Card Surg. 2021; 36: 1672-6. https://doi.org/10.1111/jocs.15054

12 Domínguez-Gil B, Coll E, Fernández-Ruiz M, Corral E, del Río F, Zaragoza R, Rubio JJ, Hernández D. COVID‐19 in Spain: Transplantation in the midst of the pandemic. Am J Transplant. 2020; 20 (9): 2593-8. https://doi.org/10.1111/ajt.15983

13 Goff RR, Wilk AR, Toll AE, McBride MA, Klassen DK. Navigating the COVID‐19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States. Am J Transplant. 2021; 21 (6): 2100-12. https://doi.org/10.1111/ajt.16411

14 Suarez-Pierre A, Choudhury R, Carroll AM, King RW, Iguidbashian J, Cotton J, Colborn KL, Kennealey PT, Cleveland JC, Pomfret E, Fullerton DA. Measuring the effect of the COVID-19 pandemic on solid organ transplantation. Am J Surg. 2022; 224 (1): 437-42. https://doi.org/10.1016/j.amjsurg.2021.12.036

15 Chadban SJ, McDonald M, Wyburn K, Opdam H, Barry L, Coates PT. Significant impact of COVID-19 on organ donation and transplantation in a low-prevalence country: Australia. Kidney Int. 2020; 98 (6): 1616-8. https://doi.org/10.1016/j.kint.2020.10.007

16 Kute VB, Godara S, Guleria S, Ray DS, Aziz F, Hegde U, Sharma A, Nayak KS, Siddini V, Sarkar P, Thukral S, Sow Mondal RR, Goswami J, Patel HV, Abraham AM, Pathak V, Anandh U, Jha PK, Bavikar S, Bonu RS, Gulati S, Kumar ABT, Yadav DK. Is it safe to be transplanted from living donors who recovered from COVID-19? Experience from India. Transplantation. 2020; 105 (4): 842-50. https://doi.org/10.1097/TP.0000000000003609

17 Viana LA, Cristelli MP, Leite VM, Nakamura MR, Custodio LFP, Carneiro VA, Amorim LVP, Martins SBS, Tedesco-Silva H, Medina-Pestana J. Transplanting kidneys from donors with SARS-CoV-2 RNA positivity in Brazil: Early success under surveillance. Transplantation. 2022; 106 (12): e517-9. https://doi.org/10.1097/TP.0000000000004353

18 International Registry in Organ Donation and Transplantation. 2022 [acesso em: Mar 27, 2022]. Disponível em: https://www.irodat.org/?p=about

19 Eurotransplant. Organization. Eurotransplant [acesso em: Mar 27, 2022]. Disponível em: https://www.eurotransplant.org/about-eurotransplant/organization/

20 WHO Global Observatory on Donation and Transplantation (GODT). [acesso em: Mar 27, 2022]. Disponível em: http://www.transplant-observatory.org/

21 Associação Brasileira de Transplante de Órgãos (ABTO). [citado Mar 27, 2022]. Disponível em: https://site.abto.org.br/

22 Brasil. Portal saúde: doação de órgãos e tecidos. Brazil: Ministério da Saúde [acesso em: Mar 13, 2022]. Disponível em: https://www.gov.br/saude/pt-br/composicao/saes/snt/transplantes

23 World Health Organization (WHO). COVID-19 Dashboard. [citado Mar 27, 2022]. Disponível em: https://covid19.who.int

24 Johns Hopkins Coronavirus Resource Center. New COVID-19 cases worldwide. [acesso em: Mar 26, 2022]. Disponível em: https://coronavirus.jhu.edu/data/new-cases

25 United Nations Development Programme. Human Development Reports. United Nations [acesso em: Set 24, 2022]. Disponível em: https://hdr.undp.org/

26 The World Bank. Indicators | Data. World Bank [acesso em: Set 7, 2022]. Disponível em: https://data.worldbank.org/indicator

27 StataCorp. Stata Statistical Software: Release 16.1. StataCorp; 2020.

28 Legeai C, Malaquin G, Lamotte C, Antoine C, Averland B, Jasseron C, Bayer F, Bastien O, Kerbaul F. Impact of COVID-19 on organ donation and transplantation in France. Transpl Int. 2021; 34: 204-6. https://doi.org/10.1111/tri.13769

29 Manara AR, Mumford L, Callaghan CJ, Ravanan R, Gardiner D. Donation and transplantation activity in the UK during the COVID-19 lockdown. Lancet. 2020; 396 (10249): 465-6. https://doi.org/10.1016/S0140-6736(20)31692-5

30 Katvan E, Cohen J, Ashkenazi T. Organ donation in the time of COVID-19: the Israeli experience—ethical and policy implications. Isr J Health Policy Res. 2022; 11: 6. https://doi.org/10.1186/s13584-022-00519-8

31 Zhang H, Dai H, Xie X. Solid organ transplantation during the COVID-19 pandemic. Front Immunol. 2020; 11: 1392. https://doi.org/10.3389/fimmu.2020.01392

32 Bartelt L, van Duin D. An overview of COVID-19 in solid organ transplantation. Clin Microbiol Infect. 2022; 28 (6): 779-84. https://doi.org/10.1016/j.cmi.2022.02.005

33 Bock MJ, Vaughn GR, Chau P, Berumen JA, Nigro JJ, Ingulli EG. Organ transplantation using COVID‐19‐positive deceased donors. Am J Transplant. 2022; 22 (9): 2203-16. https://doi.org/10.1111/ajt.17145

34 Zhang M, Wang G, Li J, Hopp WJ, Lee DD. Pausing transplants in the face of a global pandemic: Patient survival implications. Prod Oper Manag. 2022; 32 (5): 10.1111/poms.13697. https://doi.org/10.1111/poms.13697

35 Passoni R, Gadonski B, Carvalho ARS, Freitas TVS, Peres LAB. The impact of COVID-19 on kidney transplant activities in Brazil: a descriptive study. Sao Paulo Med J. 2023; 14 (1): 60-6. https://doi.org/10.1590/1516-3180.2021.0956.R1.29042022

36 Kuramitsu K, Yamanaga S, Osawa R, Hibi T, Yoshikawa M, Toyoda M, Shimata K, Yosuke E, Ono M, Kenmochi T, Sogawa H, Natori Y, Yano H, Chen-Yoshikawa T, Yoshida K, Fukumoto T, Yuzawa K, Egawa H. Impact of COVID‐19 on living donor liver and kidney transplantation programs in Japan in 2020. Transpl Infect Dis. 2022; 24 (3): e13845. https://doi.org/10.1111/tid.13845

37 Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, de Vries H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Muñoz A, Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT; ERACODA Collaborators. COVID-19–related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020; 35 (11): 1973-83. https://doi.org/10.1093/ndt/gfaa261

38 Craig-Schapiro R, Salinas T, Lubetzky M, Abel BT, Sultan S, Lee JR, Kapur S, Aull MJ, Dadhania DM. COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients. Am J Transplant. 2021; 21 (4): 1576-85. https://doi.org/10.1111/ajt.16351

39 Cravedi P, Mothi SS, Azzi Y, Haverly M, Farouk SS, Pérez-Sáez MJ, Redondo-Pachón MD, Murphy B, Florman S, Cyrino LG, Grafals M, Venkataraman S, Cheng XS, Wang AX, Zaza G, Ranghino A, Furian L, Manrique J, Maggiore U, Gandolfini I, Agrawal N, Patel H, Akalin E, Riella LV. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant. 2020; 20 (11): 3140-8. https://doi.org/10.1111/ajt.16185

40 Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, Le Goff O, Antoine C, Greze C, Pillebout E, Abboud I, Glotz D, Daugas E, Lefaucheur C. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020; 31 (10): 2413-23. https://doi.org/10.1681/asn.2020050639